Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01377012
What this trial is testing

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 637
Testing effectiveness (Phase 2)Study completedNCT00867516
What this trial is testing

Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
CSL Behring 127
Large-scale testing (Phase 3)Ended earlyNCT03970837
What this trial is testing

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 1,764
Testing effectiveness (Phase 2)Study completedNCT02047604
What this trial is testing

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bausch Health Americas, Inc. 41
Post-approval studies (Phase 4)Study completedNCT01149057
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 145
Not applicableStudy completedNCT06970964
What this trial is testing

Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race

Who this might be right for
Respiratory Tract Infections (RTI)Mucosal ImmunitySystemic Inflammation+7 more
Federal University of São Paulo 80
Post-approval studies (Phase 4)UnknownNCT03410836
What this trial is testing

Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions

Who this might be right for
Intravenous Lidocaine and Immunity
Ciusss de L'Est de l'Île de Montréal 60
Not applicableStudy completedNCT03797378
What this trial is testing

Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study

Who this might be right for
Spinal Cord InjuriesTraumatic Brain InjurySpina Bifida+4 more
University of Alabama at Birmingham 108
Testing effectiveness (Phase 2)Study completedNCT02969044
What this trial is testing

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 70
Not applicableUnknownNCT01021098
What this trial is testing

Acute Respiratory Infection Consortium

Who this might be right for
Influenza
Henry M. Jackson Foundation for the Advancement of Military Medicine 2,018
Large-scale testing (Phase 3)Study completedNCT02480153
What this trial is testing

PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 597
Large-scale testing (Phase 3)Enrolling By InvitationNCT07386587
What this trial is testing

Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
University of Child Health Sciences and Children's Hospital, Lahore 60
Large-scale testing (Phase 3)Ended earlyNCT01770379
What this trial is testing

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 242
Large-scale testing (Phase 3)Study completedNCT02115750
What this trial is testing

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Coherus Oncology, Inc. 647
Testing effectiveness (Phase 2)Study completedNCT02066389
What this trial is testing

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 300
Not applicableLooking for participantsNCT07209930
What this trial is testing

Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial

Who this might be right for
ExerciseHealthy ParticipantsGlucose Variability+1 more
University College Dublin 24
Not applicableStudy completedNCT06105463
What this trial is testing

Multiple Sclerosis, Menstrual Cycle and Physical Acivity

Who this might be right for
Multiple Sclerosis
Universidad de Almeria 15
Large-scale testing (Phase 3)Study completedNCT00993317
What this trial is testing

CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Korea Otsuka Pharmaceutical Co., Ltd. 127
Not applicableWithdrawnNCT00006578
What this trial is testing

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00002406
What this trial is testing

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 350
Next Page